main (HD) (1, 2, 26, 50) . The full-length protein, which we refer to as CDP/Cux p200, was found to be proteolytically processed at the G 1 /S transition of the cell cycle, thereby generating the CDP/Cux p110 isoform that contains three DNA binding domains, CR2, CR3, and HD (48) . In addition, two alternate, tissue-specific mRNA species were found to code for a CDP/Cux p75 isoform that contains only two DNA binding domains: CR3 and HD (23, 68) . Despite early claims made by us and others on the basis of results obtained with glutathione S-transferase (GST) fusion proteins (1, 2, 25, 26) , individual Cut repeats cannot bind to DNA on their own but need to cooperate with a second Cut repeat or with the Cut homeodomain (47) . CR1CR2 was found to make a rapid but transient interaction with DNA, whereas CR2CR3HD and CR3HD bound more slowly, but stably, to DNA (47) . Predictably, CDP/ Cux p110 and p75 exhibited DNA binding properties similar to that of CR2CR3HD and CR3HD. However, somewhat surprisingly, CDP/Cux p200 behaved like CR1CR2 and made an unstable interaction with DNA, suggesting that DNA binding by CR3HD is inhibited in the context of the full-length protein (47, 48) . The carboxy-terminal domain (CTD) of the protein was found to contain two active repression domains, and the CTD was reported to recruit histone deacetylase 1 (39, 45) . The protein was shown to repress transcription by at least two mechanisms: competition for binding site occupancy and active repression (45) . CDP/Cux was reported to repress a large number of genes, in particular those genes expressed in precursor cells prior to terminal differentiation (6, 17, 20, 28, 33-35, 37, 39, 43, 45, 51, 53, 55, 60, 63, 64, 69, 78) . In addition, the binding of CDP/Cux to a number of matrix attachment regions raises the possibility that the protein is involved in higher-order chromatin organization or may be able to target certain regulatory loci to specific regions of the nucleus (5, 16, 40, 63, 75) .
A number of studies demonstrated that CDP/Cux is regulated in a cell cycle-dependent manner and may have a specific function in S phase. The histone nuclear factor D (HiNF-D), which was later found to include CDP/Cux as its DNA binding partner, was shown to be up-regulated in S phase in normal cells (29, 70, 72, 73, 77) . The up-regulation of stable DNA binding at the G 1 /S transition was shown to involve at least two posttranslational modifications: dephosphorylation of the Cut homeodomain by the Cdc25A phosphatase and proteolytic cleavage of CDP/Cux p200 between CR1 and CR2 to generate CDP/Cux p110 (17, 48) . Later in the cell cycle, DNA binding was found to decrease in G 2 following the phosphorylation by cyclin A or Cdk1 of two serine residues, S1237 and S1270, in the region of the Cut homeodomain (58) . The rise and decline of stable DNA binding activity of CDP/Cux at the beginning and at the end of S phase suggest that the CDP/Cux p110 isoform plays a role in S phase. We reported that CDP/Cux was able to repress a reporter plasmid carrying the promoter of the p21
Waf1/Cip1 gene (17) . Moreover, inhibition of CDP/Cux expression in S phase, by way of an antisense vector, restored expression of the p21
Waf1/Cip1 reporter to the higher level observed in G 1 (17) . Interestingly, expression of another cyclin kinase inhibitor, p27, was shown to be down-regulated in the CMV/Cux-1 transgenic mice (38) .
The binding of HiNF-D to the promoters of several S phasespecific histone genes at the same time in the cell cycle when these genes are induced is consistent with the notion that HiNF-D functions as a transcriptional activator (3, 4, 36, 72, 73, 77) . However, cotransfection of CDP/Cux with a reporter containing the promoter of the FO108-H4 histone gene did not lead to the activation of this reporter but rather to its repression (72) . In contrast, in another study, cotransfection of CDP/ Cux with the ITF2 transcription factor led to the activation of a reporter containing the tyrosine hydroxylase gene promoter (79) . These results may indicate that CDP/Cux needs to cooperate with other proteins in order to mediate activation. Another difference that might explain the discrepancy between these results was that the latter study utilized an incomplete rat CDP/Cux cDNA clone that expressed an N-terminally truncated CDP/Cux protein equivalent to the p110 processed isoform (79) . The latter two possibilities are not mutually exclusive. Indeed, one can envision a complex interdependent mechanism in which transcriptional activation requires both stable DNA binding by CDP/Cux p110 and cooperation with other proteins.
In the present study, we show that CDP/Cux p110, but not CDP/Cux p200, was capable of stimulating expression of a reporter containing the promoter of the DNA polymerase ␣ (DNA pol ␣) gene. Moreover, the introduction of a truncated CDP/Cux protein by retroviral infection led to an increase in DNA pol ␣ mRNA level. Using in vitro mutagenesis and DNA binding assays, we were able to establish a correlation between the binding of CDP/Cux to DNA pol ␣ promoter sequences and the stimulation of the DNA pol ␣ reporter plasmid. The potential mechanisms by which CDP/Cux may stimulate expression of the DNA pol ␣ reporter plasmid are discussed.
MATERIALS AND METHODS
Plasmid construction. The DNA pol ␣ Ϫ1561/ϩ47 reporter plasmid was constructed as previously described (48) . In the following manner, 5Ј deletion constructs were made. Ϫ1158/ϩ47 was inserted into pGL3-Basic, and both were digested with HindIII and NcoI. Ϫ402/ϩ47 was constructed via insertion of the BssHII/NcoI promoter fragment into MluI/NcoI of pGL3-Basic; the promoter was digested with SphI, and the overhang was removed with T4 DNA polymerase, followed by digestion with NcoI, yielding Ϫ248/ϩ47, which was cloned into SmaI/NcoI of pGL3-Basic. Ϫ116/ϩ47 was made by digestion of the promoter with SacII/NcoI and was ligated with pGL3-Basic digested with SacI/NcoI. Ϫ65/ ϩ47 was made by digestion of DNA pol ␣ with EagI/NcoI and ligation into SmaI/NcoI sites of pGL3-Basic. Linker scanning mutants were made by PCR with pGL3-pol ␣ (Ϫ65/ϩ47) as a template, with the 5Ј-most primer being 5ЈA GGTACGGGAGGTACTTGGAGCGG3Ј and the 3Ј-most primer being 5ЈAT GTCGTTCGCGGGCGCAACTGCAACTC3Ј. The sequences of the inner primers can be made available upon request. Briefly, inner primers used to generate the upstream fragments had the tail sequence 5ЈGACTTGAAGCTT TC. Inner primers for the downstream fragments had the tail sequence 5ЈGAC TGAAAGCTTCA. Upstream fragments were digested with NotI/HindIII, and downstream fragments were digested with HindIII/BstBI. Upstream and downstream fragments were ligated together with pGL3-Basic digested with NotI/ BstBI. Constructs were sequenced to verify the absence of mutations. Sequences and/or maps will be provided upon request for CDP/Cux 831-1505, 831-1505, 659-1192ϩNLS, and CR2CR3HD constructs. All other CDP/Cux constructs have been described in previous studies (48, 58) .
Expression and purification of CDP/Cux fusion proteins. The full-length CDP/Cux protein was expressed in SF9 insect cells by using a baculovirus vector as previously described (47) . All truncated CDP/Cux proteins were otherwise expressed in bacteria by using the pET-15b vector (Novagen). The expression plasmids were introduced into the BL21 (DE3) strain of Escherichia coli and induced with 1 mM isopropyl-␤-D-thiogalactopyranoside for 1.5 h. Proteins were purified on nickel-nitrilotriacetic acid-agarose (Qiagen) in accordance with the manufacturer's instructions.
Cell culture, transfection, and synchronization. HeLa and C33A are human epithelial cell lines derived from cervical carcinomas (18) . HS578T, T47D, and MCF-7 are human epithelial cell lines derived from breast carcinomas (11, 24, 76) . T98G is a human fibroblastic cell line derived from a gliobastoma multiform tumor (62) . NIH 3T3, C33A, and HeLa cells were grown in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS). HS578T, T47D, and MCF-7 cells were grown in DMEM supplemented with 5% FBS. T98G cells were grown in EMEM supplemented with 10% FBS. Synchronization in G 1 /S was performed by two methods, namely, serum starvationstimulation (posttransfection, cells were maintained in DMEM plus 0.4% FBS for 36 h, followed by 18 h in DMEM plus 10% FBS) and thymidine block (posttransfection, cells were cultured overnight in DMEM plus 10% FBS supplemented with 2 mM thymidine and harvested). Transient transfections were performed with ExGen500 (MBI Fermentas) in accordance with the manufacturer's instructions.
Luciferase assay. Cells were plated in 12-well plates to be approximately 50% confluent on the day of transfection. A total of 750 ng of DNA (250 ng of reporter DNA and 500 ng of effector DNA) was transfected. Cells were either synchronized (see above) or harvested 24 to 48 h later. Luciferase assays were performed as described previously (48) . Because the internal control plasmid is itself often repressed by CDP/Cux, as a control for transfection efficiency, the purified ␤-galactosidase protein (Sigma) was included in the transfection mix, as previously described (30). The luciferase activity was then normalized based on ␤-galactosidase activity.
CDP/Cux antibodies and Western blot analysis. Antibodies 861 and 1300 have previously been described (23, 48) . To generate polyclonal antibodies against various regions of CDP/Cux (1,505 amino acids [aa]), rabbits were injected with 500 g of purified bacterial fusion protein containing various regions of CDP/ Cux in Freund's complete adjuvant. Antibodies were raised against the following regions: ␣23, aa 23 to 50; ␣403, aa 403 to 449; ␣510, aa 510 to 541; ␣861, aa 861 to 936; and ␣1300, aa 1300 to 1402. The animals were boosted twice with 250 g of protein, and serum was collected 10 days after the last boost. Polyclonal antibodies were purified by affinity chromatography. The serum was passed through two GST affinity columns, and the flowthrough was then applied to a GST-CDP/Cux affinity column to isolate antibodies.
Preparation of nuclear extracts and Western blot analysis. Nuclear extracts were prepared as described previously (48) . For Western blotting, indicated quantities of nuclear extracts were recovered as described above and were resuspended in Laemmli buffer. Proteins were then boiled for 5 min and loaded on Calculation of the DNA binding affinity. To determine the dissociation constant (K D ), EMSAs were performed essentially as described above, but with a fixed concentration of DNA (Յ10 pM) and a wide range of protein concentrations and with the following modifications. Less than 10 pM DNA was used, and protein and DNA were incubated for 15 min at room temperature. The binding affinity (K D ) was calculated using the method described by Janet Carey (14, 15) . The amount of free and bound DNA was quantitated by scanning of the autoradiograms on a phosphorimager (Amersham Pharmacia Biotech Typhoon 8600) and verified by scintillation counting of the excised bands in an independent experiment. The data were plotted as the fraction of free DNA versus the log of protein concentration. Since the protein concentrations did not take into account the fraction of inactive proteins, our data are referred to as the apparent
Oligonucleotides. The sequences of oligonucleotides used in this study are as follows: TCGAGACGATATCGATAAGCTTCTTTTC (universal CDP/Cux consensus binding site); TCGAGACGGTATCGATAGCTTCTTTTC (AT CGAT); GGGCCGCTGATTGGCTTTCAGGCTGGCGCCTCGA (DNA pol ␣ Ϫ40/Ϫ14); GGGCCGCTGAAAGCTTCACAGGCTGGCGCCTCGA (DNA pol ␣ Ϫ40/Ϫ14 mut Ϫ35/Ϫ26). Underlined sequences represent mutations introduced in linker-scanning analysis.
DNase I footprinting. The DNA pol ␣ fragment Ϫ116/ϩ47 was used for this analysis. The plasmid was 32 P labeled at the NcoI site with the Klenow fragment of DNA polymerase I and cleaved with SacII. After electrophoresis through a 5% polyacrylamide gel, the labeled fragments were purified by passive elution in 10 mM Tris-HCl (pH 7.5)-1 mM EDTA. DNase footprinting analysis was performed as previously described (25) . End-labeled DNA (8,000 cpm per tube) was incubated with purified bacterially expressed fusion proteins for 15 min at room temperature in a final volume of 75 l in 10 mM Tris (pH 7.5), 25 mM NaCl, 1 mM MgCl 2 , 1 mM dithiothreitol, 5% glycerol, and 4% (wt/vol) polyvinyl alcohol. Two hundred twenty-five microliters of 10 mM MgCl 2 -5 mM CaCl 2 was added for 90 s. Various dilutions of DNase I were added, and samples were then incubated for 90 s. At that time, 270 l of DNase stop solution (20 mM EDTA, 1% sodium dodecyl sulfate, 0.2 M NaCl) was added, and the solution was mixed by vortexing. Following phenol-chloroform extraction and ethanol precipitation, samples were electrophoresed through a 6% denaturing polyacrylamide (40:1) gel in 1ϫ Tris-borate-EDTA. Gels were dried and visualized by autoradiography.
Chromatin immunoprecipitation. Chromatin was prepared as described previously (52) with the following exception. Sonication was performed for 5 s followed by a 2-min incubation on ice, and this was repeated a total of four to six times. A single aliquot was retained for chromatin quality assessment and chromatin quality control. We estimated that 15 ϫ 10 6 to 20 ϫ 10 6 cells per aliquot would ensure similar titers of chromatin in all subsequent immunoprecipitations. To ensure quality control between experiments, protein A-agarose beads from the chromatin immunoprecipitation (ChIP) assay kit (no. 17-295; Upstate Biotechnology) were used for the immunoprecipitations. The extract was first incubated with 30 l of beads for 1 h. After centrifugation, the supernatant was transferred to a new tube and incubated overnight at 4°C with 2 g of purified CDP/Cux antibody. The next day, 25 l of beads was added, and incubation was continued for at least 1 h at 4°C. The supernatant was removed, and the beads were washed two times with low-salt buffer, two times with high-salt buffer, and then once with Tris-EDTA. Elution and DNA purification followed the protocol of Nissen and Yamamoto, with the addition of an additional phenol-chloroform extraction (52) . The presence of binding to three different regions of the DNA pol ␣ gene promoter in the immunoprecipitated chromatins was analyzed by PCR with specific sets of oligonucleotides: region 1 (PCR 1), 5ЈCCCTCAG CTCTAGCTTTTCCCTAAGGGG3Ј and 5ЈCATGGTCCCGAATCTCCCGA TTCC3Ј; region 2 (PCR 2), 5ЈGGTTCTCTCCTGGTTGGAAAAGCTTG3Ј and 5ЈTTGCCCACATGCTTATTGATCCCTTC3Ј; region 3 (PCR 3), 5ЈGGTGCC TTATTGCTCTGTTCTCACATGG3Ј and 5ЈCAGCTGATTACTTCCCACAT GCCCG3Ј. PCRs, in 50 l, were done with Taq polymerase (MBI Fermentas) for a total of 37 cycles. The temperature of hybridization corresponded to the value of the melting temperature (T m ) of the oligonucleotides for the first 6 cycles. The hybridization temperatures were decreased until 5°C below the Tm for the rest of the PCR.
In vivo DNA binding to transfected reporter plasmids. HS578T cells were transfected with pGL3-Pol ␣ (Ϫ65/ϩ47), pGL3-Pol ␣ (Ϫ65/ϩ47) mut (Ϫ35/ Ϫ26), and either pXJ42 or pXJ42/CDP/Cux CR2CR3HD. DNA was extracted approximately 24 h posttransfection. The chromatin immunoprecipitation protocol described above was used, except that samples of extracted DNA were not sonicated. Primers used in PCR are as follows: 5ЈCCGAGCCGCTGATTGGC TTT3Ј (WT) or 5ЈCCGAGCCGCTGAAAGCTTCA3Ј (mut Ϫ35/Ϫ26) was used with 5ЈAGCGGTTCCATCTTCCAGCGGATAGA3Ј.
Retroviral infections and RT-PCR. HS578T cells were infected by the addition of virus-containing supernatant from 293VSV producer cells (54) . Cells were harvested 48 h postinfection. To minimize the extent of proteolytic processing of the full-length CDP/Cux protein, cells had been plated so as to reach nearconfluence 48 h postinfection. Real-time reverse transcriptase (RT) PCR was performed with a LightCycler with the Fast Start DNA Master SYBR Green I kit (Roche) and the following primers for DNA pol ␣: sense primer, 5ЈGCTTCAC CGAATCCTTTCTCTGTG3Ј (mRNA position 581 to 604); antisense primer, 5ЈTTCCTCATCTGCCCCTTTTACC3Ј (1030 to 1009). DNA pol ␣ RNA was normalized to the amount of glyceraldehyde phospho-dehydrogenase (GAPDH) (see reference 23 for the primer sequence) RNA amplified.
RESULTS
CDP/Cux stimulates the DNA pol ␣ gene promoter during S phase in NIH 3T3 cells. A search of the promoter database with the CDP/Cux consensus binding site revealed that the proximal promoter sequences of the DNA pol ␣ gene contained several putative CDP/Cux binding sites in both Drosophila melanogaster and humans (Fig. 1) . The DNA pol ␣ gene was previously shown to be up-regulated at the transcriptional level in S phase (56) . Using RT-PCR, we confirmed that DNA pol ␣ mRNA expression was up-regulated in S phase following reentry of NIH 3T3 cells into the cell cycle (data not shown). To determine whether CDP/Cux could regulate the human DNA pol ␣ gene promoter, NIH 3T3 cells were cotransfected with a luciferase reporter plasmid containing the sequence from Ϫ1561 to ϩ47 of the human DNA pol ␣ gene and either an empty vector or a vector expressing CDP/Cux 817-1505 (Fig. 1) . This recombinant protein corresponds to the 110-kDa isoform, CDP/Cux p110, that is generated by proteolytic processing in S phase of the cell cycle (48) . CDP/Cux p110 had little or no effect on the expression of the DNA pol ␣ reporter when transfected NIH 3T3 cells were allowed to grow asynchronously ( Fig. 1A and B) . In contrast, expression of the DNA pol ␣ reporter was stimulated in the presence of CDP/ Cux p110 when NIH 3T3 cells were synchronized in S phase either by thymidine block (Fig. 1A) or by serum starvation and restimulation (Fig. 1B) . The same assay was repeated with a panel of transformed cell lines that were allowed to grow asynchronously. Significant stimulation of the DNA pol ␣ reporter was observed in HS578T, T47D, and T98G cells, and moderate levels of stimulation were observed in C33A, MCF-7, and HeLa cells (Fig. 1C) . The levels of activation may vary due to differences in transfection efficiency or levels of VOL. 23, 2003 CDP/Cux UP-REGULATES DNA pol ␣ TRANSCRIPTION 3015 endogenous CDP/Cux, which may affect the response to its overexpression. In summary, CDP/Cux p110 was able to stimulate expression of the DNA pol ␣ reporter in several cell lines; however, in NIH 3T3 cells, this stimulatory effect was dependent upon the cells being synchronized in S phase. N-terminal truncation of CDP/Cux is necessary for stimulation of the DNA pol ␣ reporter. To investigate the mechanism by which CDP/Cux was able to stimulate expression of the DNA pol ␣ reporter, the reporter assay was repeated with effector plasmids expressing CDP/Cux recombinant proteins with progressive N-terminal truncations. HS578T cells were utilized for these assays, as our preliminary experiments revealed that this line consistently displayed the highest level of stimulation by CDP/Cux. Full-length CDP/Cux protein was unable to stimulate expression and, in fact, produced what appeared to be weak repression ( Fig. 2A) . Yet, the protein expressed from this plasmid was functional, since it was able to repress a reporter plasmid carrying the promoter of the p21
Waf1/Cip1 gene, as previously published (Fig. 2B ) (17) . In contrast to full-length CDP/Cux, all N-terminally truncated Fig. 2A) . This stimulatory effect correlated well with the ability of CDP/Cux proteins to bind to a consensus binding site that is specific for CR3HD or CR2CR3HD (Fig. 2D, lanes 3 to 6) . In contrast, the full-length CDP/Cux protein, whose expression was confirmed by Western blotting (Fig. 2C, lane 1) , interacted only weakly with this sequence (Fig. 2C, lane 2) . These data are in agreement with previous studies showing that full-length CDP/Cux binds to DNA only transiently and exhibits a preference for sequences containing not just one but two CAAT or CGAT motifs (47, 48) . Thus, we conclude that p110, but not p200, is able to stimulate expression of the DNA pol ␣ reporter. The CTD is expendable, but the Cut homeodomain is re- Removal of the CTD of CDP/Cux had no effect on the reporter assay, whereas removal of the Cut homeodomain prevented stimulation of the DNA pol ␣ reporter (Fig. 3A) . All CDP/Cux proteins were expressed at high levels, as observed by Western blot analysis (Fig. 3B ). All recombinant proteins bound to DNA efficiently with the exception of CDP/Cux 659-1192, in which the Cut homeodomain was deleted (Fig. 3C , compare lane 5 with lanes 2 to 4). We conclude that the Cut homeodomain is required for the stimulation of the DNA pol ␣ reporter. In summary, results from mapping analysis demonstrated that aa 1 to 1061 and 1301 to 1505 are dispensable. Moreover, the presence of the N-terminal portion of the protein, from aa 1 to 659, and the absence of the Cut homeodomain will prevent the stimulatory function of CDP/Cux. While the mapping data presented were obtained in the HS578T cell line, similar results were obtained in NIH 3T3 cells (data not shown). These results are consistent with the notion that CDP/Cux must be able to make a stable interaction with DNA in order to stimulate expression from the DNA pol ␣ reporter. CDP/Cux can stimulate the expression of reporter plasmids containing the promoter sequences of other S phase-specific genes. To verify whether stimulation of gene expression by CDP/Cux was unique to the DNA pol ␣ promoter, we tested promoter sequences from a number of genes whose expression is up-regulated in S phase. As a control, we also tested a reporter containing the core promoter of the p21
Waf1/Cip1 gene. This reporter was previously shown to be repressed by CDP/ Cux in cotransfection assays (17, 58) . Cotransfection with CDP/Cux CR2CR3HD did not affect the expression of the p21 Waf1/Cip1 reporter. It is likely that repression of the p21 Waf1/Cip1 promoter by CDP/Cux requires the action of the active repression domains present in the CTD. In contrast, reporter plasmids carrying the promoters from the dihydrofolate reductase (DHFR), carbamoyl-phosphate synthase-aspartate carbamoyltransferase-dihydroorotase (CAD), and cyclin A genes were stimulated by CDP/Cux CR2CR3HD, albeit to a lesser extent than what was observed with the DNA pol ␣ reporter (Fig. 4) .
CDP/Cux can stimulate the core promoter of the DNA pol ␣ gene. To identify the DNA pol ␣ promoter sequences that are required for stimulation by CDP/Cux, a series of reporter plasmids with progressive 5Ј deletions were tested in the cotransfection assays. CDP/Cux stimulated the expression of all reporter plasmids, including one plasmid carrying DNA pol ␣ sequences from Ϫ65 to ϩ47 (Fig. 5A) . We conclude that the core promoter of the DNA pol ␣ gene contains sequences that allow its stimulation in the presence of CDP/Cux.
Linker scanning mutations were introduced into the Ϫ65/ ϩ47 DNA pol ␣ reporter plasmid. These mutations consisted of the serial replacement of 10-bp sequences with the sequence GAAAGCTTCA. Two replacement mutations, at positions Ϫ35 to Ϫ26 and Ϫ25 to Ϫ16, significantly reduced the ability of CDP/Cux CR2CR3HD to stimulate gene expression (Fig. 5B) .
CDP/Cux CR2CR3HD can bind to the core DNA pol ␣ gene promoter in vitro. DNase footprinting analysis was performed to verify whether CDP/Cux proteins containing the two DNA binding domains CR2 and CR3 along with the Cut homeodomain (CR2CR3HD), or those containing just CR3HD, would interact with the core DNA pol ␣ gene promoter. A DNA fragment was end labeled at position ϩ47, incubated with purified bacterially expressed His-CR2CR3HD or His-CR3HD protein, and treated with DNase I. A protected region was observed between nucleotides (nt) Ϫ14 and Ϫ40 of the coding strand (Fig. 6A, lanes 2 and 6 to 7) . Interestingly, an inverted CCAAT motif resides within this interval, at position Ϫ30 to Ϫ34. EMSA with double-stranded oligonucleotides corresponding to nt Ϫ40 to Ϫ14 confirmed that the purified His-CR2CR3HD protein could form a strong retarded complex with this sequence (Fig. 6B, lane 2) . In contrast, the full-length CDP/Cux protein was unable to make a stable interaction with the DNA pol ␣ sequence (Fig. 6D, lanes 6  to 9) . A mutation that reduces stimulation of expression in vivo also reduces DNA binding in vitro. Two assays were performed to verify whether the replacement mutation at position Ϫ35/ Ϫ26 would reduce the affinity of His-CR2CR3HD for this sequence. In the first assay, wild-type or mutated Ϫ40/Ϫ14 oligonucleotides were used as cold competitors in EMSA with the wild-type Ϫ40/Ϫ14 probe. Whereas a 100-fold excess of the wild-type oligonucleotides completely eliminated the retarded FIG. 5 . CDP/Cux can stimulate the core DNA pol ␣ gene promoter. (A) HS578T cells were cotransfected with DNA pol ␣ reporter constructs with progressive 5Ј deletions and either an empty vector or a vector expressing CDP/Cux CR2CR3HD. Luciferase assays were performed as described. Results are expressed as activation relative to that of the Ϫ1561/ϩ47 reporter, which was assigned a value of 100%. (B) Linker scanning mutations were introduced at 10-bp intervals within the reporter construct containing the core DNA pol ␣ gene promoter. Mutations consisted of the replacement of the indicated sequence with the sequence GAAAGCTTCA. HS578T cells were cotransfected with the indicated reporter constructs and either an empty vector or a vector expressing CDP/Cux CR2CR3HD. Luciferase assays were performed as described in the legend to Fig. 1A . Results are expressed as activation relative to that of the wild-type Ϫ65/ϩ47 reporter, which was assigned a value of 100%. complex, the oligonucleotides with the Ϫ35/Ϫ26 replacement mutation did not compete as efficiently (Fig. 6B, lanes 3 and 4) . In the second assay, oligonucleotides with the Ϫ35/Ϫ26 replacement mutation were used as an EMSA probe. The His-CR2CR3HD protein was able to generate a complex, although the intensity of the complex appeared weaker than that of the wild-type sequence (Fig. 6B, compare lanes 2 and 6) . Moreover, as we had seen previously, the wild-type oligonucleotides were more efficient competitors than the mutated ones (Fig.  6B, lanes 7 and 8) .
The DNA binding affinity for the wild-type and mutated oligonucleotides was assessed by performing EMSA with a fixed concentration of DNA (Յ10 pM) and a wide range of protein concentrations (Fig. 6C) Ϫ7 M for the wild-type and mutated oligonucleotides, respectively (Fig. 6C) . Thus, the Ϫ35/Ϫ26 replacement mutation reduced the affinity of CR2CR3HD for the core DNA pol ␣ promoter by a factor of approximately 2.2-fold. In other experiments, we found that the Ϫ25/Ϫ16 replacement mutation that also reduced the stimulatory effect of CDP/Cux on the DNA pol ␣ reporter did not affect the interaction of CDP/Cux with the DNA pol ␣ promoter sequences in vitro (data not shown). We postulate that this mutation interferes with the binding of another protein that participates in the transcriptional activation of the DNA pol ␣ promoter and is required for the stimulatory effect of CDP/Cux.
In summary, a CDP/Cux protein containing CR2CR3HD was able to stimulate expression of a reporter containing the sequence Ϫ65 to ϩ47 from the DNA pol ␣ gene promoter. This stimulatory effect was abolished by the replacement of the sequence from Ϫ35 to Ϫ26 or Ϫ25 to Ϫ16. In vitro, a purified CDP/Cux protein containing CR2CR3HD was able to interact with the core DNA pol ␣ promoter sequences; however, the replacement of the sequence from Ϫ35 to Ϫ26 diminished the affinity of CDP/Cux for the DNA pol ␣ promoter. Thus, a correlation was established between the stimulation of the core DNA pol ␣ gene promoter in vivo and the interaction of CDP/Cux with DNA pol ␣ promoter sequences in vitro.
CDP/Cux binds the DNA pol ␣ gene promoter in vivo, specifically during the S phase of the cell cycle. ChIP assays were performed to investigate whether endogenous CDP/Cux proteins bind to the promoter of the DNA pol ␣ gene in vivo. Primers were designed to amplify three different regions of the DNA pol ␣ gene promoter and one region upstream of the GAPDH gene promoter. With total chromatin as a template, each pair of primers amplified a DNA fragment of the expected molecular weight (Fig. 7A, lane 3) . With chromatin obtained after immunoprecipitation with the anti-CDP/Cux antibody 861, an amplified fragment was observed for the regions from Ϫ1179 to Ϫ843 and Ϫ173 to ϩ47 (Fig. 7A , lane 2, PCR 1 and 2). In contrast, no fragment was obtained with primers for the GAPDH gene promoter or the upstream region of the DNA pol ␣ gene promoter between nt Ϫ1505 and Ϫ1229 (Fig. 7A, lane 2, GAPDH and PCR3 ). Controls consisted of template chromatin that was obtained following immunoprecipitation with either anti-immunoglobulin G (IgG) or anti-hemagglutinin (HA) antibodies. No amplified fragment was observed with any of the primer pairs (Fig. 7A, lanes 4 and   5) . We conclude that CDP/Cux can interact with the DNA pol ␣ gene promoter in vivo. We note also that a more intense signal was obtained in the region from Ϫ1179 to Ϫ843 than in the proximal promoter region (Fig. 7A, lane 2 , compare PCR 1 and 2). The reason for this is not entirely clear but may involve the fact that this region of the promoter contains a higher concentration of sequence motifs that match the CDP/ Cux consensus binding site (see the map in Fig. 1 ). To verify whether the association of CDP/Cux with the DNA pol ␣ gene promoter is regulated during the cell cycle, we performed ChIP assays on synchronized HS578T cells. Binding to PCR regions 1 and 2 was detected specifically in S phase (Fig. 7B, lane 2) . CDP/Cux did not interact with the DNA pol ␣ gene promoter in G 2 /M or G 1 (Fig. 7B, lanes 3 and 4) .
To verify whether the full-length CDP/Cux protein can interact with the DNA pol ␣ gene promoter in vivo, ChIP assays were performed with a panel of antibodies that recognize various regions of CDP/Cux (see the diagram in Fig. 7C ). Three of these antibodies, namely, antibodies 23, 403, and 510, recognize only the full-length protein, while antibodies 861 and 1300 can bind to both the full-length and the processed isoforms (Fig. 7C, rightmost panel) . As a control, ChIP assays were performed with IgG. The signal obtained with this sample was taken as background and attributed with a value of 1. Significantly stronger signals were observed with samples obtained with antibodies 861 and 1300. In contrast, samples obtained with antibodies that recognize only the full-length protein did not generate a stronger signal than background. We cannot exclude the possibility that the epitope recognized by an antibody is masked when the protein is bound to DNA. However, it becomes difficult to evoke this possibility to explain the absence of amplification with three different antibodies. The results rather suggest that the full-length CDP/Cux protein does not make a stable interaction with the DNA pol ␣ gene promoter.
Reduction in stimulation of gene expression correlates with a decrease in DNA binding in vivo. Since we observed a correlation between a decrease in DNA binding in vitro and a reduction in the stimulation of gene expression in transfection assays with the linker scanning mutant Ϫ35/Ϫ26, we considered the possibility that the decreased affinity of CDP/Cux for this mutant precluded the recruitment of CDP/Cux to the reporter plasmid following transfection into cells. To test this hypothesis, we designed oligonucleotide primers that would specifically amplify sequences from either the wild type or the Ϫ35/Ϫ26 mutant reporter plasmid. In preliminary experiments, the wild-type primers were found to efficiently amplify the wild-type, but not the mutated, sequence, whereas the mutated primers amplified the mutated, but not the wild-type, sequence (Fig. 8A) . HS578T cells were cotransfected with both the wild-type and the mutated reporter plasmids together with either an empty vector or a vector coding for CDP/Cux CR2CR3HD. With total chromatin, a fragment of the expected molecular weight was amplified with each pair of primers to verify that the cells had each received the two plasmids as expected (Fig. 8B, lanes 2 to 3 and 8 to 9 ). Faint amplified fragments were observed when chromatin obtained by immunoprecipitation with the preimmune serum or chromatin derived from cells that had received the empty effector plasmid was used as a template (Fig. 8, lanes 4 to 7 and 10 to 11) . We The results are expressed as levels of activation using as a control the anti-IgG sample which was given a value of 1. In the rightmost panel, nuclear extracts from HS578T cells were subjected to immunoprecipitation with the indicated antibodies, followed by immunoblotting with the 1300 antibody. Below is a schematic representation of CDP/Cux isoforms and the regions recognized by the respective antibodies. The evolutionarily conserved domains are indicated (CC, coiled-coil; CR1, CR2 and CR3, Cut repeats 1, 2 and 3; HD, homeodomain).
VOL. 23, 2003 CDP/Cux UP-REGULATES DNA pol ␣ TRANSCRIPTION 3023 think this is due to the fact that a small, background amount of CDP/Cux is immunoprecipitated with beads alone, regardless of the buffer used. However, when the chromatin was first subjected to immunoprecipitation with the anti-CDP/Cux antibody, a fragment of strong intensity was amplified by the wild-type primers but not by the mutated primers (Fig. 8, lanes  12 and 13) . This result indicates that in cells containing both the wild-type and the mutated reporter plasmids, the recombinant CDP/Cux protein was able to interact efficiently with the wild-type reporter plasmid but not with the mutated plasmid. Fig. 7 ). PCRs were performed with either wild-type or mutated plasmid DNA template and the corresponding primers, as indicated. (B) CDP/Cux in vivo binds to the wild-type DNA pol ␣ reporter but not to the Ϫ35/Ϫ26 mutant reporter. HS578T cells were cotransfected with the wild type and mutant Ϫ35/Ϫ26 reporter construct and either an empty vector or a vector expressing CDP/Cux CR2CR3HD. After 2 days, ChIP assays were performed with the indicated primers and antibodies. As control, the PCRs were performed in parallel using total chromatin (lane 3). Abbreviations: Pre-I, preimmune serum; CDP, antibody 1300, a CDP/Cux-specific antibody; wt, wild type; mut, mutant.
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by Western blot analysis (Fig. 9B) . RT-PCR analysis was used to quantitate DNA pol ␣ mRNA ( 
DISCUSSION
The CDP/Cux transcription factor was originally characterized as a transcriptional repressor (6, 17, 20, 28, 33-35, 37, 39, 43, 45, 51, 53, 55, 60, 63, 64, 69, 78) . Recently, it was shown that an N-terminally truncated isoform, CDP/Cux p110, is generated by proteolytic processing at the G 1 /S transition of the cell cycle. Results from the present study revealed that CDP/Cux p110 is able to stimulate transcription from a reporter plasmid containing the DNA pol ␣ promoter (Fig. 1 to 5) . Moreover, expression of the endogenous DNA pol ␣ gene was stimulated in a population of cells infected with a retrovirus expressing a truncated CDP/Cux protein (Fig. 9) . These results suggest, yet do not demonstrate, that CDP/Cux p110 can function as a transcriptional activator. Stimulation of transcription, whether of a reporter or an endogenous gene, is consistent with a number of possible mechanisms. CDP/Cux p110 might directly activate transcription. It is unlikely that CDP/Cux p110 functions like a classical transcriptional activator with a DNA binding domain and an activation domain. No region of CDP/Cux was found to function as an activation domain in the Gal4 fusion assay, in which various regions of a protein are fused to the DNA binding domain of the Gal4 transcription factor and are assayed together with a Gal4 reporter plasmid (45) . Therefore, we envision that CDP/Cux p110 might contribute, perhaps as an architectural factor, to the formation of a larger complex or enhanceosome (22) . This mode of action would be consistent with what we know of the HiNF-D complex, which includes CDP/Cux as well as a number of other proteins, and whose presence on the promoter of histone genes coincides with their induction in S phase (3, 4, 36, 67, (70) (71) (72) (73) .
In light of the well-characterized role of CDP/Cux as a transcriptional repressor, we cannot exclude the possibility that CDP/Cux p110 represses the expression of another repressor that down-modulates the DNA pol ␣ promoter. Indeed, as cells were harvested 48 h posttransfection or -infection, any regulatory effect might be direct or indirect. However, we did not obtain any evidence in support of a repression mechanism. DNA fragments containing sequences from Ϫ65 to ϩ47 of the DNA pol ␣ promoter were tested in EMSA and DNase footprinting analyses. Using protein extracts from cells overexpressing CDP/Cux, we did not observe a decrease or disappearance of a retarded complex (data not shown). It still remains possible that CDP/Cux p110 interferes with the binding of a repressor that could not be detected in unfractionated nuclear extracts. In contrast to the lack of evidence in favor of a repression mechanism, we were able to establish a correlation between transcriptional stimulation and the ability of CDP/Cux p110 to bind to the DNA pol ␣ promoter sequences in EMSA and ChIP assays. These results strongly suggest, yet do not prove, that CDP/Cux p110 functioned as a true activator. More direct evidence that CDP/Cux p110 may function as a transcriptional activator would be provided if the addition of CDP/Cux p110 to an in vitro transcription system led to transcriptional activation. Again, however, in a crude in vitro system we could not exclude the possibility that CDP/Cux p110 stimulates transcription by competing with, and displacing, a repressor. Therefore, we do not think that experimental evidence from a single assay will be sufficient to demonstrate one mechanism of action at the expense of another. Instead, the accumulation of evidence from a panoply of assays and experimental conditions will gradually build a case in favor of one mechanism.
A recombinant CDP/Cux protein corresponding to CDP/ Cux p110 was able to stimulate transcription, but the fulllength CDP/Cux isoform was not (Fig. 2 and 9) . These results indicate that stimulation of transcription is a specific property of CDP/Cux p110 that is not shared with CDP/Cux p200. As CDP/Cux p110 is capable of making a stable interaction with DNA, whereas CDP/Cux p200 is not, the need for N-terminal truncation is likely to reflect the requirement for stable DNA binding. This would be compatible with the two mechanisms cited above: direct activation and repression of a repressor. CDP/Cux was previously shown to repress by two mechanisms: active repression and competition for binding site occupancy (45) . While competition can be accomplished via transient or stable DNA binding, active repression was shown to involve the recruitment of a histone deacetylase (39) . Similarly, transcriptional activation has been associated with the recruitment of histone acetyltransferases, chromatin-remodeling machines, general transcription factors, and/or the stabilization of other site-specific transcription factors (7, 12, 22, 61, 74) . Although this has not been formally tested, it is generally assumed that a DNA-binding transcription factor must be able to make a stable interaction with DNA in order to participate in transcriptional activation or active repression. In the case of CDP/ Cux, it is clear that proteolytic processing modifies its DNA binding properties. It is possible that another consequence of processing is to change the ability of CDP/Cux to interact with other proteins.
One linker mutation between nt Ϫ25 and Ϫ16 abolished transcriptional stimulation by CDP/Cux but did not affect its affinity for the core promoter (Fig. 5B and data not shown) . It is likely that this mutation interferes with the binding of another protein that participates in the transcriptional activation of the DNA pol ␣ promoter and is required for the stimulatory effect of CDP/Cux. This protein could be another transcription factor or one of the components of the preinitiation complex.
Results from ChIP assays showed that two regions of the DNA pol ␣ gene promoter could be immunoprecipitated with CDP/Cux, the core promoter and a region approximately 1 kbp upstream. The latter was immunoprecipitated more efficiently, yet we found that the core promoter of the DNA pol ␣ gene was sufficient to allow its stimulation in reporter assays. This result does not exclude the possibility that the upstream sequences may also contribute to the recruitment of CDP/Cux to the DNA pol ␣ gene promoter. We envision that the core promoter, which contains a low-affinity binding site for CDP/ Cux p110, was able to recruit CDP/Cux p110 when the protein was overexpressed in transfected cells, but it is possible that the upstream sequences play an important role in the recruitment of CDP/Cux p110 when the protein is expressed at physiological levels. In agreement with this notion, we found that a substantial fraction of purified CDP/Cux p110 elutes as a multimeric complex on a size exclusion column (L. Leduy and A. Nepveu, unpublished observations). Whether CDP/Cux p110 can multimerize in vivo and how this process is regulated should be addressed in future studies.
Earlier studies on the HiNF-D factor pointed to a role of CDP/Cux in the S phase of the cell cycle (29, 70, 72, 73, 77) . More recently, various posttranslational modifications of CDP/ Cux were shown to regulate its DNA binding activity in a cell cycle-dependent manner (17, 48, 58) . Results presented herein have revealed a novel activity of this transcription factor that pertains to its role in cell cycle progression: CDP/Cux p110 is capable of stimulating, directly or indirectly, the promoters of DNA pol ␣ and other genes that are induced in S phase. Future studies should ascertain the role of CDP/Cux p110 as a transcriptional activator. Another important issue will be to evaluate the role of CDP/Cux in the regulation of the cell cycle in various cell types. Unless the cux-1 and cux-2 genes are partially redundant, the fact that cux homozygous knock-out mice did not exhibit embryonic lethality indicates that cux-1 is not an essential gene (21, 44, 59 ). Yet, some phenotypes of the cux-1 homozygous knockout mice, like the smaller size of the mice, their defect in hair growth, and their reduced numbers of B and T cells, are compatible with a role of cux-1 in the proliferation of at least certain cells. Interestingly, these phenotypes are in striking contrast with the multiorgan hyperplasia and organomegaly displayed by a cux-1 transgenic mouse (38) . The identity of the cells in which CDP/Cux contributes to proliferation and the developmental signals to which CDP/Cux responds should be the subject of intense investigation in the future.
